Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copaxone in acute optic neuritis
NCT00856635Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Feb 2009
- Primary completion
- Dec 2010
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of glatiramer acetate in optic neuritis (ON), sponsored by Teva Pharmaceutical Industries Ltd.. Started Feb 2009; status: completed.
02
Drugs
glatiramer acetate
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on NCT00856635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00856635.